An immunosuppressive factor interacts with membrane glycolipid asialo-GM1 structure. 1987

K C Wang, and C R Verret, and R K Yu, and R K Gershon, and S Lee

An immunosuppressive factor was isolated from sheep-erythrocyte hyperimmunized mouse serum. Possibilities of the adsorption of the immunosuppressive factor with glycolipid asialo-GM1 incorporated liposome (dipalmitoyl lecithin) and the blockade of immunosuppressive activity by specific anti-asialo-GM1 incorporated antibody were tested. We report here that: The immunosuppressive activity of the immunosuppressive factor decreased quantitatively if the factor was preincubated with asialo-GM1 incorporated liposome (GALP) as compared with that preincubated with liposome (LP) alone; and the presence of specific anti-asialo-GM1 antibody is able to protect in vitro anti-sheep erythrocyte (SRBC) response from the suppressive effect of the immunosuppressive factor in a dose-dependent fashion under similar cell culture condition. The results indicate that asialo-GM1 may be related to the receptor of immunosuppressive factor.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008563 Membrane Lipids Lipids, predominantly phospholipids, cholesterol and small amounts of glycolipids found in membranes including cellular and intracellular membranes. These lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside. Membrane lipids are required for active transport, several enzymatic activities and membrane formation. Cell Membrane Lipid,Cell Membrane Lipids,Membrane Lipid,Lipid, Cell Membrane,Lipid, Membrane,Lipids, Cell Membrane,Lipids, Membrane,Membrane Lipid, Cell,Membrane Lipids, Cell
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005677 G(M1) Ganglioside A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis. GM1 Ganglioside,Monosialosyl Tetraglycosyl Ceramide,GM1a Monosialoganglioside,Ceramide, Monosialosyl Tetraglycosyl,Ganglioside, GM1,Monosialoganglioside, GM1a,Tetraglycosyl Ceramide, Monosialosyl
D006028 Glycosphingolipids Lipids containing at least one monosaccharide residue and either a sphingoid or a ceramide (CERAMIDES). They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids (GANGLIOSIDES); SULFOGLYCOSPHINGOLIPIDS (formerly known as sulfatides), glycuronoglycosphingolipids, and phospho- and phosphonoglycosphingolipids. (From IUPAC's webpage) Asialoganglioside,Asialogangliosides,Glycosphingolipid,Sphingoglycolipid,Sphingoglycolipids
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

K C Wang, and C R Verret, and R K Yu, and R K Gershon, and S Lee
May 1982, FEBS letters,
K C Wang, and C R Verret, and R K Yu, and R K Gershon, and S Lee
January 1987, Microbiology and immunology,
K C Wang, and C R Verret, and R K Yu, and R K Gershon, and S Lee
November 1985, Molecular immunology,
K C Wang, and C R Verret, and R K Yu, and R K Gershon, and S Lee
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
K C Wang, and C R Verret, and R K Yu, and R K Gershon, and S Lee
December 2004, Nihon rinsho. Japanese journal of clinical medicine,
K C Wang, and C R Verret, and R K Yu, and R K Gershon, and S Lee
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
K C Wang, and C R Verret, and R K Yu, and R K Gershon, and S Lee
March 1998, Journal of immunological methods,
K C Wang, and C R Verret, and R K Yu, and R K Gershon, and S Lee
October 1994, Infection and immunity,
K C Wang, and C R Verret, and R K Yu, and R K Gershon, and S Lee
November 1980, Journal of immunology (Baltimore, Md. : 1950),
K C Wang, and C R Verret, and R K Yu, and R K Gershon, and S Lee
December 1993, Infection and immunity,
Copied contents to your clipboard!